We are live on ! Find out more
AHPI

Allied Healthcare Products

Delisted

AHPI was delisted on the 2nd of February, 2023.

15 hedge funds and large institutions have $7.86M invested in Allied Healthcare Products in 2013 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

15% more funds holding

Funds holding: 13 → 15 (+2)

0.53% less ownership

Funds ownership: 43.73% → 43.2% (-0.53%)

53% less capital inflows, than outflows

Capital inflows: $94.5K | Capital outflows: $202K

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

AHPI Hedge Fund Activity: Q3 2013 in Review

15 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q3 2013, worth a combined $7.86M — down 19% from $9.7M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new AHPI positions and 0 closed out — a net gain of 2 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Oppenheimer & Close, adding an estimated $44.2K. The largest seller was Wells Fargo, cutting an estimated $181K.

  • 15 institutional investors held Allied Healthcare Products (AHPI) as of Q3 2013, up from 13 in Q2 2013.
  • Funds reported $7.86M of Allied Healthcare Products stock for Q3 2013, down 19% quarter-over-quarter.
  • 2 funds opened new Allied Healthcare Products positions in Q3 2013 and 0 closed out, a net change of +2 holders.
  • The largest Allied Healthcare Products buyer in Q3 2013 was Oppenheimer & Close, an estimated $44.2K added.
  • The largest Allied Healthcare Products seller in Q3 2013 was Wells Fargo, an estimated $181K sold.

Based on aggregated 13F filings for Q3 2013.